Login
Request Demo
Case studies

Case Study: Treatment patterns in mantle cell lymphoma (MCL)

Learn how Prospection helped a pharma client understand the real-world utilization of medicines for mantle cell lymphoma (MCL). With depth of experience and analytics expertise, Prospection was able to identify patient treatment profiles using Australian Pharmaceutical Benefits Scheme (PBS) data. The insights from the analysis guided important decisions around launch planning, submission modelling, and medical communications planning for the client.
Download Now

Introduction 

Mantle cell lymphoma (MCL) is a rare and usually aggressive subtype of non – Hodgkin lymphoma (NHL) affecting the outer edge (mantle) of the lymph nodes. MCL most commonly affects men over the age of 50 years and accounts for approximately 5% to 10% of all NHL cases.1 As MCL is rare, limited information is available on patient characteristics, outcomes, treatment and management strategies of patients with the condition.

Our client’s challenge

In this case study, our client wanted to know if and how treatment patterns for MCL had changed over the past ten years, since the introduction of newer novel agents. The analysis, focused specifically on current treatment patterns, time to next treatment (TTNT), duration of treatment, overall survival (OS) and outcomes of patients with MCL. The insights from this analysis would help our client understand the real-world utilisation of medicines in the Australian treatment setting and dictate medical engagement, access communications and launch planning.

……………. Download full case study here:

Speak to Prospection today to learn more about about the Prospection platform and its analytics capabilities.

Case Study: Treatment patterns in mantle cell lymphoma (MCL)

Download Now
healthdata analyticsMCLpatient outcomesrare diseasesreal world datareal world evidence

Related Resources

Published Research: Otsuka sheds light on Myelodysplasia Treatment in Australia with Patient-centric Intelligence

A recent study in eJHaem led by Anoop Enjeti, MD, PhD, in collaboration with Otsuka and Prospection, highlights the importance of treatment adherence and the need for more treatment options for Myelodysplastic Syndromes (MDS). It also showcases the critical role...

Published Research: How Johnson & Johnson Innovative Medicine Used Patient-centric Intelligence in Japan to Understand Care Advancements for Pulmonary Arterial Hypertension

A recent study by Johnson & Johnson Innovative Medicine Asia Pacific, in collaboration with Prospection, utilised patient-centric intelligence (PCI) in Japan to evaluate the persistence of endothelin receptor antagonists in pulmonary arterial hypertension (PAH) treatment.

Case Study: Treatment patterns in chronic lymphocytic leukaemia (CLL)

Learn how Prospection analysed real-world data and identified a shift towards newer novel agents for chronic lymphocytic leukemia (CLL) treatment, providing insights to support their client's launch planning, submission modelling and market preparations for their new treatment. Prospection analysed treatment...

Case Study: Treatment persistence in Crohn's disease

Check out our case study on Crohn's disease (CD) treatment outcomes to learn how Prospection helped support the decisions a pharma company made related to strategy, communication, education, and clinical support for its brand. Their data-driven decision process was fuelled...